Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Dickson

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Journal of Adolescent and Young Adult Oncology|July 15, 2024
Harmonization of the Upfront Osteosarcoma Treatment Paradigm for Adolescents and Young AdultsNicole P Daukshus, Viswatej Avutu, Emily Long Sarro, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2010
A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridolMark A Dickson, Manish A Shah, Dana Rathkopf, et al.
Cancer Medicine|June 4, 2021
Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shotAnna Lee, Jung J Kang, Havah Bernstein, et al.
Journal of Medical Virology|December 12, 2022
Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcomaLilly Gu, Erica Lin, Shuaitong Liu, et al.
Oncogene|May 24, 2018
PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescenceMary E Klein, Mark A Dickson, Cristina Antonescu, et al.
Human Pathology|December 27, 2014
Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironmentSandra P D'Angelo, Alexander N Shoushtari, Narasimhan P Agaram, et al.
Oncology|June 6, 2015
Outcomes of Systemic Therapy for Patients with Metastatic AngiosarcomaSandra P D'Angelo, Rodrigo R Munhoz, Deborah Kuk, et al.
Oncoimmunology|January 4, 2018
Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trialDavid J Chung, Richard D Carvajal, Michael A Postow, et al.
Oncotarget|March 25, 2015
MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibitionMarta Kovatcheva, David D Liu, Mark A Dickson, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2017
A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumoursMaja de Jonge, Vincent A de Weger, Mark A Dickson, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Journal of Adolescent and Young Adult Oncology|July 15, 2024
Harmonization of the Upfront Osteosarcoma Treatment Paradigm for Adolescents and Young AdultsNicole P Daukshus, Viswatej Avutu, Emily Long Sarro, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2010
A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridolMark A Dickson, Manish A Shah, Dana Rathkopf, et al.
Cancer Medicine|June 4, 2021
Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shotAnna Lee, Jung J Kang, Havah Bernstein, et al.
Journal of Medical Virology|December 12, 2022
Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcomaLilly Gu, Erica Lin, Shuaitong Liu, et al.
Oncogene|May 24, 2018
PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescenceMary E Klein, Mark A Dickson, Cristina Antonescu, et al.
Human Pathology|December 27, 2014
Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironmentSandra P D'Angelo, Alexander N Shoushtari, Narasimhan P Agaram, et al.
Oncology|June 6, 2015
Outcomes of Systemic Therapy for Patients with Metastatic AngiosarcomaSandra P D'Angelo, Rodrigo R Munhoz, Deborah Kuk, et al.
Oncoimmunology|January 4, 2018
Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trialDavid J Chung, Richard D Carvajal, Michael A Postow, et al.
Oncotarget|March 25, 2015
MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibitionMarta Kovatcheva, David D Liu, Mark A Dickson, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2017
A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumoursMaja de Jonge, Vincent A de Weger, Mark A Dickson, et al.
Pageof 8